EGFR and non-small cell lung carcinoma: We reported a case of SJS after sequential use of EGFR-TKIs and toripalimab in an NSCLC patient with <i>EGFR</i> mutations 19 del/T790M/C797S in <i>trans</i> and <i>cis</i>.